The 2023 PDA Good Aseptic Manufacturing Conference will take place on 23-24 May 2023 in Leipzig, Germany.
We are pleased to announce that we will co-chair this face-to-face event.
An optional site visit of the IDT Biologika will take place on 25 May. Limited places are available, so make sure to register.
The new EU GMP Annex 1 is now officially published and to take effect in August 2023. One of the most important new requirements is the implementation of a contamination control strategy. Furthermore, decisions and processes should have their rationale in a risk-based approach.
The revised EU GMP Annex 1 will be the core of our conference. We are happy to invite you to submit a paper or poster abstract to present on your novel approaches and/or ongoing challenges.
It will be a great occasion to share efficient and sustainable solutions in implementing the requirements of EU GMP Annex 1, including new methods, innovation tools, and developments covering new technologies, equipment, and utilities. Abstracts must be non-commercial in nature, describing new developments or challenges and solutions that significantly contribute to the body of knowledge relating to Aseptic Manufacturing.
The Scientific Program Planning Committee will review all proposals carefully and consider podium and poster contributions.
We very much hope to meet you in Leipzig next year.
Kerstin Wilken, IDT Biologika
Paul Devuyst, GSK
SCIENTIFIC PROGRAM PLANNING COMMITTEE:
- Kerstin Wilken, IDT Biologika
- Paul Devuyst, GSK
- Darren Beckett, Sterility Solutions
- Simone Biel, Merck
- Richard Denk, SKAN
- Rainer Glöckler, Swissfillion
- Gabriele Gori,Thermo Fisher
- Rob Hendrix, Janssen Pharma
- David Keen, Ecolab
- Arne Kloke, Alliance to Zero on behalf of SCHOTT Pharma
- Peter Makowenskyj, GCon Bio
- Tracy Moore, TM Pharma Group
- Davor Pavetic, Sandoz
- Andrea Salmaso, Stevanato
- Helen Sauter, Vetter Pharma
- Carrie Horton PDA
- Falk Klar, PDA Europe
- Caroline Lynar, Junior Manager Programs & Events, PDA Europe